Sunny Kumar

Sunny Kumar is a Partner at Informed Ventures and GSR Ventures, where he invests in early-stage enterprise software companies utilizing artificial intelligence to transform healthcare delivery. As a physician trained at Stanford University, he holds both an MD and an MBA, bridging clinical informatics and translational medicine with commercial applications. Prior to his venture capital career, Kumar founded multiple healthcare startups, including a voice-enabled natural language processing platform designed to reduce hospital readmissions, and has experience scaling operations to hundreds of millions of dollars in revenue. He recently led funding for Autopoiesis Sciences to advance research in model reasoning and actively tracks digital health funding trends, projecting market normalization at $10 billion to $15 billion annually. Ultimately, his current investment focus centers on the intersection of machine learning, neurosurgery, and gene therapy to improve patient outcomes.